CANF
Can-Fite BioPharma American Depositary Shares
CANF
CANF
10 hedge funds and large institutions have $1.87M invested in Can-Fite BioPharma American Depositary Shares in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Holders
10
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$461K | |
| 2 | +$56.2K | |
| 3 | +$33.7K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$15K |
Top Sellers
| 1 | -$130K | |
| 2 | -$37.5K | |
| 3 | -$12K | |
| 4 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
-$9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.75K |